Tiratricol is a medicine for people with MCT8 deficiency, also called Allan-Herndon-Dudley syndrome, a rare genetic condition. It acts like thyroid hormone and can get into cells without the missing transporter, which helps bring too-high thyroid hormone levels in the body back down. It comes as a tablet that is mixed with water into a liquid and swallowed.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Tiratricol, sold as Emcitate, is a prescription medicine for MCT8 deficiency, also called Allan-Herndon-Dudley syndrome. This rare inherited condition mainly affects boys and men. A faulty gene leaves the body without MCT8 (monocarboxylate transporter 8), a transporter that thyroid hormone needs to get into many cells, including brain cells. The result is a split problem. The brain gets too little thyroid hormone, which contributes to the severe developmental and movement difficulties the condition causes. Meanwhile, the active thyroid hormone T3 (triiodothyronine) builds up in the blood, and the rest of the body behaves as if it had an overactive thyroid. Doctors call this peripheral thyrotoxicosis. It can cause a fast heart rate, high blood pressure, poor weight gain and muscle wasting. Emcitate is approved in the US for adults and children with MCT8 deficiency to treat that body-wide thyroid excess. It is not a treatment for ordinary hypothyroidism, and it is not meant for anyone without this diagnosis.
Tiratricol is a close chemical relative of T3 that switches on the same thyroid hormone receptors inside cells. The key difference is that it does not need the MCT8 transporter to get in. Inside the pituitary gland and brain centers that regulate the thyroid, tiratricol acts like a signal that there is already enough thyroid hormone. The pituitary then sends less stimulation to the thyroid gland, and blood T3 levels fall toward normal. Because tiratricol also acts on tissues such as the heart and liver, it can stand in for the hormone it is lowering without leaving the body short of thyroid activity.
Emcitate comes as a small scored tablet that is not swallowed. Each dose is dispersed in room-temperature drinking water inside an oral syringe and given as a cloudy liquid, either squirted gently into the inside of the cheek or put through a feeding tube into the stomach. Tablets should not be swallowed whole, chewed or crushed, and they should not be mixed with juice, food or tube-feeding formula. The prepared liquid is used within 30 minutes. The FDA-approved Instructions for Use walk through each step. Treatment starts at a low dose based on body weight and is usually raised about every two weeks until blood T3 falls into the lower half of the normal range for the person's age. The daily amount can be given once a day or split into two or three doses. If a dose is vomited within 30 minutes, it is given again; if vomiting happens a second time, call the care team. Doses should not be doubled after a missed dose. Emcitate should not be stopped suddenly, because thyroid excess can come back; stopping is done by lowering the dose in steps every two weeks.
In the studies behind the approval, the most common side effects were diarrhea, vomiting, rash and heavy sweating. The side effects that matter most come from too much thyroid effect, usually while the dose is being raised. Early on, the body's own high T3 has not yet fallen while tiratricol is already working, and later a dose can simply be higher than a person needs. Signs include a faster heart rate, higher blood pressure, diarrhea, sweating, irritability, trouble sleeping and nightmares. Many people with MCT8 deficiency cannot describe how they feel, so caregivers are often the ones who notice these changes. New or worsening signs should be reported to the care team, which usually lowers the dose until they settle.
Emcitate carries the FDA boxed warning shared by thyroid hormone medicines: it must not be used for weight loss or obesity, where it can cause serious or life-threatening thyroid excess. It should not be used by people with primary hyperthyroidism (an overactive thyroid gland). Other thyroid medicines, including levothyroxine and antithyroid drugs such as propylthiouracil, are generally avoided alongside it because the combination can push thyroid activity too high or too low. Stimulants, such as caffeine and ADHD medicines like amphetamines, are not recommended with it because they can add to a fast heart rate and higher blood pressure. Tiratricol can strengthen the effect of warfarin-type blood thinners and raise bleeding risk, so clotting tests are watched closely. Iron and calcium supplements can reduce how much is absorbed and are best given at the same time each day relative to Emcitate, while acid-reducing medicines called proton pump inhibitors can increase absorption. Tell the care team about every medicine and supplement, and about starting or stopping one. There is no information on use in pregnancy or breastfeeding.
The first few months are a dose-finding period, with T3 blood tests roughly every two weeks and checks of heart rate and blood pressure. These tests need a lab method called mass spectrometry. Tiratricol makes the standard T3 blood test read falsely high, so it is worth confirming that every lab drawing blood knows the person takes it. Once the dose is stable, T3 is usually rechecked about every six months. In a 12-month study of 46 boys and men, average T3 fell from about twice the upper limit of normal into the normal range, resting heart rate dropped by about nine beats a minute, and blood pressure and weight-for-age improved modestly. A later review of people treated for up to six years found that these improvements lasted. What tiratricol has not been shown to do is improve intellectual or motor development. The trials measured blood levels and body signs, not brain development, so it should be understood as treatment for the body-wide effects of the condition. Whether starting very early in life changes development is still being studied. For children under 8, doctors may suggest periodic eye checks, because very high doses caused cataracts in animal studies, though the risk at human doses is thought to be low.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Emcitate (Tiratricol), what you've noticed, or ask the community a question.